MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dopamine"

  • 2016 International Congress

    Temporal working memory deficit in Parkinson’s disease

    B. Degos, I. Ameqrane, S. Rivaud-Péchoux, P. Pouget, M. Missal (Paris, France)

    Objective: To investigate whether temporal working memory (TWM) could be impacted in Parkinson's disease (PD). We also tested whether idiopathic PD patients (iPD) could be…
  • 2016 International Congress

    Improved motor functioning of people with Parkinson’s disease following dance intervention

    S.M. Simone, K.A. Beben, S.E. Maguire, C. Noudga, K.L.M. Martin, G.N. Luabeya, P. Dhami, R.J. Bar, J.F. DeSouza (Toronto, ON, Canada)

    Objective: To investigate the effectiveness of dance as an additional treatment for people with Parkinson's disease (PD). Background: Common pharmacological treatments for PD lessen the…
  • 2016 International Congress

    Emotional valence and arousal ratings from rewarding and fearful stimuli are not influenced by levodopa in Parkinson’s disease

    T. Serranova, T. Sieger, P. Dušek, E. Ruzicka, R. Jech (Prague, Czech Republic)

    Objective: To analyze the effects of levodopa on affective ratings of emotional valence and arousal to rewarding, fearful and neutral stimuli in PD patients and…
  • 2016 International Congress

    Prognostic factors of motor symptoms in Parkinson’s disease using neuromelanin imaging and the relationship with (123)I-FP-CIT-SPECT

    A. Okuzumi, T. Hatano, K. Kamagata, M. Hori, S. Aoki, N. Hattori (Tokyo, Japan)

    Objective: This study aimed to examine the relationship between findings of neuromelanin sensitive MRI findings and motor complications. We also examined the correlation of findings…
  • 2016 International Congress

    Are limbic and cognitive effects on balance in Parkinson’s disease equal?

    K.A. Ehgoetz Martens, C.G. Ellard, Q.J. Almeida (Camperdown, Australia)

    Objective: The main objective of this study was to evaluate: (i)whether highly anxious PD (HA-PD) have a reduced capacity for information processing compared to PD…
  • 2016 International Congress

    Rasagiline treatment for sleep disorders in Parkinson’s disease (RaSPar) – Double-blinded, randomized, placebo-controlled, placebo run-in-phase, polysomnography clinical trial

    W. Schrempf, M. Fauser, K. Otto, M. Wienecke, C. Ossig, S. Brown, A. Maass, M.D. Brandt, U. Schwanebeck, X. Graehlert, H. Reichmann, A. Storch (Dresden, Germany)

    Objective: To study the effects of Rasagiline on sleep disturbances measured by polysomnographic (PSG) evaluation of sleep efficacy and secondary measures as other sleep variables,…
  • 2016 International Congress

    Frequency and factors associated with neuropathic pain in patients with Parkinson’s disease

    J.F. Pascacio-Astudillo, A.L. Bazàn-Rodrìguez, M. Rodrìguez-Violante, A. Cervantes-Arriaga (Mèxico City, Mexico)

    Objective: To determine the prevalence of neuropathic pain in PD and association between neuropathic pain, duration of PD, treatment with Levodopa, cumulative dose, non-motor symptoms…
  • 2016 International Congress

    Dynamic dopamine transporter images are helpful for diagnosing parkinsonism

    K. Abe, K. Fukushima, T. Katuura, K. Kitajima, Y. Maeda, K. Hahiskawa, H. Yoshikawa (Nishinomiya, Japan)

    Objective: This study is aimed at introducing a new method to get Dopamine transporter (DAT) imaging simultaneously with regional cerebral flow (CBF) imaging. Background: DAT…
  • 2016 International Congress

    Response inhibition in Parkinson’s disease

    J. Kim, K. Zhang, M.A.I.U.A. Cruadhlaoich, S. YorkWilliams, V. Menon, K.L. Poston (Stanford, CA, USA)

    Objective: To study the brain networks underlying Response Inhibition in Parkinson's disease (PD). Background: While some PD patients can have significant executive dysfunction, others remain…
  • 2016 International Congress

    Beta – blockers worsen vascular parkinsonism in patients with concomitant coronary heart disease

    A. Turakhonov, S. Dadajonov, R. Sadikov, R. Khodjaev, S. Nurov (Tashkent, Uzbekistan)

    Objective: Our primary aim was to study the effect of beta - blockers on the dynamics of extrapyramidal disorders in patients suffering from coronary heart…
  • « Previous Page
  • 1
  • …
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley